Raghavendar T Nagaraju

5PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer diagnosisInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 15, 2024
CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness.

Xiaodan Qin, Andrew Lam, Xu Zhang

|Sep 26, 2023
PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models.

Chun Wai Wong, Christos Evangelou, Kieran N Sefton

|Dec 01, 2020
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation.

Jorge Barriuso, Raghavendar T Nagaraju, Shreya Belgamwar

|Mar 14, 2019
Enhanced Fatty Acid Scavenging and Glycerophospholipid Metabolism Accompany Melanocyte Neoplasia Progression in Zebrafish.

Fiona Henderson, Hannah R Johnston, Andrew P Badrock

|Oct 04, 2016
CD4-Transgenic Zebrafish Reveal Tissue-Resident Th2- and Regulatory T Cell-like Populations and Diverse Mononuclear Phagocytes.

Christopher T Dee, Raghavendar T Nagaraju, Emmanouil I Athanasiadis

Pageof 1

Frequent Collaborators

3 joint publications

Adam Hurlstone

2 joint publications

Christos Evangelou

2 joint publications

Michael P Smith

1 joint publications

Christopher T Dee